#Germany #Oberkochen #AACR 2026 #Mindpeak #Revolune

Revolutionizing Spatial Biology at AACR 2026

In a significant announcement on April 16, 2026, Revolune GmbH, a leading life science company, unveiled its partnership with MindPeak, an innovator in AI-driven pathology analysis. Together, they will present their integrated multiplex immunofluorescence (mIF) workflow at the American Association for Cancer Research (AACR) Annual Meeting, scheduled for April 2026. This collaboration combines Revolune's advanced mIF reagents with MindPeak's cutting-edge image analysis capabilities, aiming to streamline and enhance spatial biology research.

As the importance of multiplex immunofluorescence grows in the pursuit of understanding tumor biology, immune interactions, and the spatial context of biomarkers, researchers often encounter challenges with complex workflows that can hinder scalability. To address this, the collaboration between Revolune and MindPeak aims to provide a more unified and efficient approach to spatial biology.

A Unified Approach

Florian Leiss, CEO of Revolune, emphasized the necessity for robust experimental methodologies coupled with reliable data interpretation in spatial biology. He stated, "By merging our state-of-the-art multiplex IF chemistry with MindPeak's powerful AI-based analysis capabilities, we can simplify the process from tissue sample collection to actionable spatial insights."

MindPeak's revolutionary AI-driven pathology software plays a pivotal role in this collaboration. It automates the analysis of complex multiplex imaging data, which assists in quantitative biomarker evaluation and spatial understanding of intricate tissue samples. Felix Faber, CEO of MindPeak, expressed excitement about this venture, saying, "We are thrilled to collaborate with Revolune, enabling researchers to overcome the obstacles that often slow down the adoption of spatial biology workflows."

The AACR 2026 Experience

Attendees at AACR 2026 will have the opportunity to explore the newly integrated workflow and engage in discussions on how these advanced staining and analysis solutions can facilitate translational cancer research and enhance biomarker discovery. The representatives from Revolune and MindPeak invite all participants to visit their booth (#1660) to gain deeper insight into how integrated methodologies can simplify spatial biology workflows.

About Revolune

Revolune is committed to enhancing spatial biology through innovative multiplex immunofluorescence solutions that combine efficacy with simplicity. By developing cutting-edge reagent technologies targeted towards clarity and confidence in research, the company enables scientists to uncover significant biological insights from complex tissue systems.

About MindPeak

Established in 2018, MindPeak stands at the forefront of digital pathology, leveraging AI to bridge the gap between biomarker developments and clinical diagnostics. Their advanced AI technology empowers laboratories with the ability to extract meaningful insights from various tissue images, enhancing both routine diagnostics and the application of novel biomarkers in real clinical contexts.

As the AACR 2026 approaches, the excitement around these innovative technologies continues to grow, promising transformative advancements in the field of cancer research and treatment. Keep an eye on the developments that arise from this revolutionary partnership that aims to simplify the path through complex biological landscapes.